Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimian Group ABCHIX:VIMIAS 77 Piotroski F-Score is 6 as of Aug. 23, 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates CHIX:VIMIAS with a GF Score™ of 77/100 and a GF Value™ of kr31.00. The stock has 4 warning signs investors should review. Among 209 Medical Diagnostics & Research companies, Vimian Group AB ranks better than 78.47% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Vimian Group AB has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Vimian Group AB's Piotroski F-Score or its related term are showing as below:
CHIX:VIMIAs'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 5 Max: 7
Current: 6
During the past 9 years, the highest Piotroski F-Score of Vimian Group AB was 7. The lowest was 2. And the median was 5.
Vimian Group AB (CHIX:VIMIAs) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Vimian Group AB Piotroski F-Score Related Terms
Vimian Group AB Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Vimian Group AB's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:VIMIAS vs TMO, DHR, IDXX: Piotroski F-Score Comparison
For the Diagnostics & Research subindustry, Vimian Group AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimian Group AB Piotroski F-Score vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Vimian Group AB's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 71.505 + 131.676 + 105.559 + 92.085 = kr401 Mil. Cash Flow from Operations was 118.809 + 606.145 + 247.741 + 41.658 = kr1,014 Mil. Revenue was 1147.386 + 1186.173 + 1249.474 + 1333.047 = kr4,916 Mil. Gross Profit was 795.359 + 802.027 + 873.555 + 912.085 = kr3,383 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(12520.587 + 12348.422 + 12077.197 + 12460.274 + 12995.016) / 5 = kr12480.2992 Mil. Total Assets at the begining of this year (Jun25) was kr12,521 Mil. Long-Term Debt & Capital Lease Obligation was kr2,999 Mil. Total Current Assets was kr2,652 Mil. Total Current Liabilities was kr1,090 Mil.
Net Income was -23.841 + 140.332 + 47.104 + 91.407 = kr255 Mil.
Revenue was 994.518 + 1206.625 + 1177.596 + 1148.647 = kr4,527 Mil. Gross Profit was 694.8 + 801.732 + 819.388 + 794.031 = kr3,110 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(11249.334 + 12011.866 + 12765.605 + 12037.766 + 12520.587) / 5 = kr12117.0316 Mil. Total Assets at the begining of last year (Jun24) was kr11,249 Mil. Long-Term Debt & Capital Lease Obligation was kr3,186 Mil. Total Current Assets was kr2,532 Mil. Total Current Liabilities was kr1,037 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Vimian Group AB's current Net Income (TTM) was 401.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Vimian Group AB's return on assets of this year was 0.03201328. Vimian Group AB's return on assets of last year was 0.02266819.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Vimian Group AB's gearing of this year was 0.24032725. Vimian Group AB's gearing of last year was 0.26293874.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Vimian Group AB's current ratio of this year was 2.4336024. Vimian Group AB's current ratio of last year was 2.44055187.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Vimian Group AB's number of shares in issue this year was 529.323. Vimian Group AB's number of shares in issue last year was 524.202.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Vimian Group AB's gross margin of this year was 0.6881552. Vimian Group AB's gross margin of last year was 0.68691978.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Vimian Group AB's asset turnover of this year was 0.39263974. Vimian Group AB's asset turnover of last year was 0.40245814.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
0
+
1
+
0
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Vimian Group AB has an F-score of 6 indicating the company's financial situation is typical for a stable company.
Vimian Group AB (CHIX:VIMIAS) has a Piotroski F-Score of 6 as of Aug. 23, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Vimian Group AB and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, Vimian Group AB's Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Vimian Group AB ranks #45 out of 209 companies in the Medical Diagnostics & Research industry, placing it in the top 21.5%.
Is Vimian Group AB's Piotroski F-Score too high?
Vimian Group AB's current Piotroski F-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Vimian Group AB's value of 6 is 20% above this industry median. Based on the distribution chart, Vimian Group AB ranks #45 out of 209 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vimian Group AB has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Vimian Group AB's Piotroski F-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimian Group AB ranks #45 out of 209 companies for Piotroski F-Score. This places Vimian Group AB in the top 22% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Vimian Group AB's value of 6 is 20% above this benchmark. Historically, Vimian Group AB's own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Vimian Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimian Group AB's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Vimian Group AB and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimian Group AB's current Piotroski F-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimian Group AB stock overvalued right now?
Vimian Group AB (CHIX:VIMIAS) has a current Piotroski F-Score of 6. The stock's GF Value™ is kr31.00, compared to a current price of kr30.28 — trading 2.3% below its estimated fair value. The current Piotroski F-Score is 6, which is 20% above median its 10-year median of 5.00 and 20% above the Medical Diagnostics & Research industry median of 5.00. Vimian Group AB's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Vimian Group AB (CHIX:VIMIAS), the current Piotroski F-Score is 6 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimian Group AB (CHIX:VIMIAS) Overvalued in 2026?
Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued.
The current stock price of kr30.28 is trading 2.3% below its estimated GF Value™ of kr31.00.
Key valuation signals for CHIX:VIMIAS:
Piotroski F-Score: 6 (20% above median its 10-year median of 5.00)
GF Value™: kr31.00 vs. price of kr30.28 (2.3% below fair value)
Industry Position: 20% above the Medical Diagnostics & Research median (#45 of 209)
No single metric tells the full story. See the CHIX:VIMIAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
77GF Score
Get the complete analysis for CHIX:VIMIAS
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:VIMIAS has been successfully added to your 
